Diagnostics
News and analysis on diagnostic technologies and applications.
Invitae More Than Doubles Q2 Revenues
The company reported $116.3 million in revenues compared to $46.2 million a year ago, which exceeded Wall Street expectations.
TwinStrand Biosciences Sues Guardant Health for Alleged Patent Infringement
The company argued in its complaint that Guardant's liquid biopsy assays have willfully infringed its patented duplex sequencing technology.
Sorrento Therapeutics, National Institute of Genomic Medicine of Mexico to Form SARS-CoV-2 Alliance
The partners will work together on a range of products for the diagnosis and treatment of SARS-CoV-2, which will be commercialized in Mexico.
Burning Rock Biotech, Impact Therapeutics Partner on CDx for PARP Inhibitor Senaparib
The NGS firm will work with Impact to develop companion diagnostics to select patients eligible for Impact's synthetic lethality drugs, beginning with senaparib.
FDA Grants EUAs for SARS-CoV-2 Tests From Thermo Fisher Scientific, Phase Scientific International
Thermo Fisher's molecular test uses targets across three genomic regions to ensure accurate detection, while Phase Scientific's antigen test can be used at the point of care.